ASSEMBLY BIOSCIENCES, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Assembly Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Assembly Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $202M, a 10% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $202M +$18.4M +10% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $184M +$26.9M +17.1% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $157M +$25.8M +19.6% Dec 31, 2021 10-K 2023-03-22
Q4 2020 $131M +$22.8M +21% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $109M +$21M +24% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $87.5M +$23.8M +37.4% Dec 31, 2018 10-K 2020-03-04
Q4 2017 $63.7M -$14M -18% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $77.7M +$11.4M +17.3% Dec 31, 2016 10-K 2018-03-08
Q4 2015 $66.3M +$8.18M +14.1% Dec 31, 2015 10-K 2017-03-02
Q4 2014 $58.1M +$11.1M +23.6% Dec 31, 2014 10-K 2016-03-11
Q4 2013 $47M +$11.6M +32.7% Dec 31, 2013 10-K/A 2015-03-16
Q4 2012 $35.4M +$9.13M +34.8% Dec 31, 2012 10-K 2014-03-31
Q4 2011 $26.3M Dec 31, 2011 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.